{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:56:37Z","timestamp":1781632597895,"version":"3.54.5"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32DA013911"],"award-info":[{"award-number":["T32DA013911"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K23DA054363"],"award-info":[{"award-number":["K23DA054363"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["T32AI052074"],"award-info":[{"award-number":["T32AI052074"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The persistent incidence of HIV among people who inject drugs (PWID) underscores the urgency for HIV prevention efforts to end the HIV epidemic. Little is known about the role carceral settings play as touchpoints for HIV testing in this population. The objectives of this study were to characterize patterns and sources of HIV testing among PWID and to understand how carceral facilities fit into this population\u2019s HIV testing landscape.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Secondary analysis of cross-sectional survey data of PWID in the Boston metro area from the 2015 and 2018 cycles of the National HIV Behavioral Surveillance (NHBS). Among self-reported HIV-negative participants, we examined incarceration and HIV testing histories and used a multivariable modified Poisson regression model to evaluate the association between incarceration history (main exposure) and past-year HIV testing (primary outcome).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 957 participants, average age was 38.9 (SD 11.1) years, 70.1% were male, 15.2% were Hispanic (of any race), 8.4% were non-Hispanic Black, and 68.1% were non-Hispanic White. Regarding incarceration experiences, 43.5% of participants reported past-year incarceration, and 41.8% reported a history of incarceration but only prior to the past year. Among those with past-year incarceration, 23.4% said their last HIV test was done at a jail or prison. Adjusting for other characteristics, compared to no incarceration history, past-year incarceration (PR 1.39; 95% CI: 1.29, 1.49) and incarceration prior to the past year (PR 1.19; 95%CI: 1.02, 1.38) were both associated with a greater prevalence of past-year HIV testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Among PWID, incarceration was very common and was a substantial source of HIV testing. However, more testing is still needed\u2014in both community and carceral settings\u2014to reach optimal testing rates in this key population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-026-26437-x","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T09:33:53Z","timestamp":1769765633000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Incarceration history and HIV testing among people who inject drugs in the Boston metro area: a pooled cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4564-6705","authenticated-orcid":false,"given":"Benjamin J.","family":"Bovell-Ammon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shauna","family":"Onofrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5029-9384","authenticated-orcid":false,"given":"Simeon D.","family":"Kimmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8255-8387","authenticated-orcid":false,"given":"Alysse G.","family":"Wurcel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Monina","family":"Klevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"26437_CR1","unstructured":"Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2015\u20132019. HIV Surveillance Supplemental Report. 2021;26(1). Available from: https:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv-surveillance.html. Cited 2024 Feb 27."},{"key":"26437_CR2","unstructured":"Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2017\u20132021. HIV Surveillance Supplemental Report. 2023;28(3). Available from: https:\/\/stacks.cdc.gov\/view\/cdc\/149080. Cited 2024 Feb 27."},{"key":"26437_CR3","unstructured":"Brown CM. MDPH Clinical Advisory: Statewide Outbreak of HIV Infection in Persons who Inject Drugs, February 5, 2019. Massachusetts Department of Public Health; 2019 Feb p. 2. Available from: https:\/\/www.mass.gov\/files\/documents\/2019\/02\/07\/statewide%20advisory%20hiv%20in%20pwid%202-5-19.docx?_ga=2.182212583.1590938026.1659456172-1778656474.1644510133."},{"key":"26437_CR4","unstructured":"Massachusetts Department of Public Health, Bureau of Infectious Disease and Laboratory Sciences. Massachusetts HIV Epidemiologic Profile: Data as of 1\/1\/2022, Population Report: Persons Who Inject Drugs. 2023. Available from: https:\/\/www.mass.gov\/lists\/hivaids-epidemiologic-profiles. Cited 2024 Feb 6."},{"issue":"6","key":"26437_CR5","doi-asserted-by":"publisher","first-page":"e64789","DOI":"10.1371\/journal.pone.0064789","volume":"8","author":"B Tempalski","year":"2013","unstructured":"Tempalski B, Pouget ER, Cleland CM, Brady JE, Cooper HLF, Hall HI, et al. Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992\u20132007. PLOS ONE. 2013;8(6):e64789. Available from: https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0064789. Cited 2022 July 18.","journal-title":"PLOS ONE"},{"key":"26437_CR6","doi-asserted-by":"publisher","unstructured":"Lansky A, Finlayson T, Johnson C, Holtzman D, Wejnert C, Mitsch A, et al. Estimating the Number of Persons Who Inject Drugs in the United States by Meta-Analysis to Calculate National Rates of HIV and Hepatitis C Virus Infections. PLOS ONE. 2014;9(5):e97596. Available from: https:\/\/journals.plos.org\/plosone\/article?id=https:\/\/doi.org\/10.1371\/journal.pone.0097596. Cited 2022 July 19.","DOI":"10.1371\/journal.pone.0097596"},{"key":"26437_CR7","doi-asserted-by":"publisher","unstructured":"Bradley H, Hall E, Asher A, Furukawa N, Jones CM, Shealey J, et al. Estimated number of people who inject drugs in the United States. Clinical Infectious Diseases. 2022;ciac543. https:\/\/doi.org\/10.1093\/cid\/ciac543. Cited 2022 July 19.","DOI":"10.1093\/cid\/ciac543"},{"key":"26437_CR8","doi-asserted-by":"crossref","unstructured":"Mattson CL. Trends and Geographic patterns in drug and synthetic opioid overdose deaths \u2014 United States, 2013\u20132019. MMWR Morb Mortal Wkly Rep. 2021;70. Available from: https:\/\/www.cdc.gov\/mmwr\/volumes\/70\/wr\/mm7006a4.htm. Cited 2022 July 18.","DOI":"10.15585\/mmwr.mm7006a4"},{"key":"26437_CR9","doi-asserted-by":"crossref","unstructured":"O\u2019Donnell JK. Trends in Deaths Involving Heroin and Synthetic Opioids Excluding Methadone, and Law Enforcement Drug Product Reports, by Census Region \u2014 United States, 2006\u20132015. MMWR Morb Mortal Wkly Rep. 2017;66. Available from: https:\/\/www.cdc.gov\/mmwr\/volumes\/66\/wr\/mm6634a2.htm. Cited 2022 July 19.","DOI":"10.15585\/mmwr.mm6634a2"},{"key":"26437_CR10","doi-asserted-by":"publisher","first-page":"103368","DOI":"10.1016\/j.drugpo.2021.103368","volume":"95","author":"A Board","year":"2021","unstructured":"Board A, Alpren C, Hernandez B, Murray A, Dawson EL, Drumhiller K, et al. A qualitative study of injection and sexual risk behavior among unstably housed people who inject drugs in the context of an HIV outbreak in Northeast Massachusetts, 2018. Int J Drug Policy. 2021;95:103368. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0955395921002735. Cited 2022 July 19.","journal-title":"Int J Drug Policy."},{"key":"26437_CR11","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.drugpo.2019.10.004","volume":"74","author":"BH Lambdin","year":"2019","unstructured":"Lambdin BH, Bluthenthal RN, Zibbell JE, Wenger L, Simpson K, Kral AH. Associations between perceived illicit fentanyl use and infectious disease risks among people who inject drugs. Int J Drug Policy. 2019;74:299\u2013304. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6949008\/. Cited 2022 July 20.","journal-title":"Int J Drug Policy."},{"issue":"1","key":"26437_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2105\/AJPH.2019.305366","volume":"110","author":"C Alpren","year":"2019","unstructured":"Alpren C, Dawson EL, John B, Cranston K, Panneer N, Fukuda HD, et al. Opioid use fueling HIV transmission in an urban setting: an outbreak of hiv infection among people who inject drugs\u2014Massachusetts, 2015\u20132018. Am J Public Health. 2019;110(1):37\u201344. Available from: https:\/\/ajph.aphapublications.org\/doi\/10.2105\/AJPH.2019.305366.","journal-title":"Am J Public Health."},{"issue":"5 Suppl 1","key":"26437_CR13","doi-asserted-by":"publisher","first-page":"S160","DOI":"10.1016\/j.amepre.2021.04.037","volume":"61","author":"SE Buskin","year":"2021","unstructured":"Buskin SE, Erly SJ, Glick SN, Lechtenberg RJ, Kerani RP, Herbeck JT, et al. Detection and Response to an hiv cluster: people living homeless and using drugs in seattle. Washington Am J Prev Med. 2021;61(5 Suppl 1):S160\u20139.","journal-title":"Washington Am J Prev Med"},{"issue":"1","key":"26437_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/0033354921994202","volume":"137","author":"NW Furukawa","year":"2022","unstructured":"Furukawa NW, Weimer M, Willenburg KS, Kilkenny ME, Atkins AD, Paul McClung R, et al. Expansion of preexposure prophylaxis capacity in response to an hiv outbreak among people who inject drugs-cabell County, West Virginia, 2019. Public Health Rep. 2022;137(1):25\u201331.","journal-title":"Public Health Rep"},{"issue":"3","key":"26437_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMoa1515195","volume":"375","author":"PJ Peters","year":"2016","unstructured":"Peters PJ, Pontones P, Hoover KW, Patel MR, Galang RR, Shields J, et al. HIV infection linked to injection use of Oxymorphone in Indiana, 2014\u20132015. N Engl J Med. 2016;375(3):229\u201339.","journal-title":"N Engl J Med"},{"key":"26437_CR16","unstructured":"Centers for Disease Control and Prevention. HIV Infection Risk, Prevention, and Testing Behaviors among Persons Who Inject Drugs\u2014National HIV Behavioral Surveillance: Injection Drug Use, 23 U.S. Cities, 2018. 2020 p. 43. Report No.: 24. Available from: https:\/\/www.cdc.gov\/hiv\/pdf\/library\/reports\/surveillance\/cdc-hiv-surveillance-special-report-number-24.pdf. Cited 2021 June 16."},{"key":"26437_CR17","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.drugalcdep.2016.05.024","volume":"165","author":"LA Cooley","year":"2016","unstructured":"Cooley LA, Wejnert C, Spiller MW, Broz D, Paz-Bailey G, NHBS study Group. Low HIV testing among persons who inject drugs-National HIV Behavioral Surveillance, 20 U.S. cities, 2012. Drug Alcohol Depend. 2016;165:270\u20134.","journal-title":"Drug Alcohol Depend."},{"issue":"9","key":"26437_CR18","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jama.2019.1343","volume":"321","author":"AS Fauci","year":"2019","unstructured":"Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV epidemic: a plan for the United States. JAMA. 2019;321(9):844\u20135. https:\/\/doi.org\/10.1001\/jama.2019.1343. Cited 2022 July 21.","journal-title":"JAMA."},{"key":"26437_CR19","unstructured":"Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(RR-14):1\u201317. Available from: https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr5514a1.htm. Cited 2024 Feb 8."},{"issue":"42","key":"26437_CR20","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.15585\/mmwr.mm7042a1","volume":"70","author":"S Handanagic","year":"2021","unstructured":"Handanagic S, Finlayson T, Burnett JC, Broz D, Wejnert C, National HIV Behavioral Surveillance Study Group. HIV infection and HIV-associated behaviors among persons who inject drugs \u2014 23 Metropolitan statistical areas, United States, 2018. MMWR Morb Mortal Wkly Rep. 2021;70(42):1459\u201365.","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"3","key":"26437_CR21","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.amepre.2020.09.011","volume":"60","author":"JJ Earlywine","year":"2021","unstructured":"Earlywine JJ, Bazzi AR, Biello KB, Klevens RM. High prevalence of indications for pre-exposure prophylaxis among people who inject drugs in Boston Massachusetts. Am J Prev Med. 2021;60(3):369\u201378. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379720304451. Cited 2022 July 12.","journal-title":"Am J Prev Med"},{"issue":"1","key":"26437_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12889-018-6314-8","volume":"19","author":"AR Bazzi","year":"2019","unstructured":"Bazzi AR, Drainoni ML, Biancarelli DL, Hartman JJ, Mimiaga MJ, Mayer KH, et al. Systematic review of HIV treatment adherence research among people who inject drugs in the United States and Canada: evidence to inform pre-exposure prophylaxis (PrEP) adherence interventions. BMC Public Health. 2019;19(1):31.","journal-title":"BMC Public Health"},{"issue":"9","key":"26437_CR23","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1037\/amp0000744","volume":"75","author":"VA Earnshaw","year":"2020","unstructured":"Earnshaw VA. Stigma and substance use disorders: a clinical, research, and advocacy agenda. Am Psychol. 2020;75(9):1300\u201311. Available from: https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=pdh&AN=2020-99903-024&site=ehost-live&scope=site. Cited 2022 Feb 28.","journal-title":"Am Psychol"},{"key":"26437_CR24","doi-asserted-by":"publisher","first-page":"102714","DOI":"10.1016\/j.drugpo.2020.102714","volume":"78","author":"O Falade-Nwulia","year":"2020","unstructured":"Falade-Nwulia O, Sacamano P, McCormick SD, Yang C, Kirk G, Thomas D, et al. Individual and network factors associated with HCV treatment uptake among people who inject drugs. Int J Drug Policy. 2020;78:102714. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0955395920300554. Cited 2021 Oct 12.","journal-title":"Int J Drug Policy."},{"issue":"8","key":"26437_CR25","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1080\/10826084.2016.1268630","volume":"52","author":"N Flath","year":"2017","unstructured":"Flath N, Tobin K, King K, Lee A, Latkin C. Enduring consequences from the war on drugs: how policing practices impact HIV risk among people who inject drugs in baltimore city. Subst Use Misuse. 2017;52(8):1003\u201310.","journal-title":"Subst Use Misuse"},{"key":"26437_CR26","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2147\/SAR.S183256","volume":"9","author":"R Hammarlund","year":"2018","unstructured":"Hammarlund R, Crapanzano K, Luce L, Mulligan L, Ward K. Review of the effects of self-stigma and perceived social stigma on the treatment-seeking decisions of individuals with drug- and alcohol-use disorders. Subst Abuse Rehabil. 2018;9:115\u201336. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6260179\/. Cited 2021 Oct 12.","journal-title":"Subst Abuse Rehabil."},{"issue":"7","key":"26437_CR27","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1089\/jwh.2010.2328","volume":"20","author":"JP Meyer","year":"2011","unstructured":"Meyer JP, Springer SA, Altice FL. Substance abuse, violence, and HIV in women: a literature review of the syndemic. J Women\u2019s Health. 2011;20(7):991\u20131006. Available from: https:\/\/www.liebertpub.com\/doi\/full\/10.1089\/jwh.2010.2328. Cited 2022 July 21.","journal-title":"J Women\u2019s Health."},{"issue":"1","key":"26437_CR28","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3109\/16066359.2015.1068301","volume":"24","author":"KT Phillips","year":"2016","unstructured":"Phillips KT. Barriers to practicing risk reduction strategies among people who inject drugs. Addict Res Theory. 2016;24(1):62\u20138.","journal-title":"Addict Res Theory"},{"issue":"2","key":"26437_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0955-3959(02)00007-5","volume":"13","author":"T Rhodes","year":"2002","unstructured":"Rhodes T. The \u2018risk environment\u2019: a framework for understanding and reducing drug-related harm. Int J Drug Policy. 2002;13(2):85\u201394. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0955395902000075. Cited 2021 May 4.","journal-title":"Int J Drug Policy."},{"issue":"12","key":"26437_CR30","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S1473-3099(18)30538-3","volume":"18","author":"N Zaller","year":"2018","unstructured":"Zaller N, Brinkley-Rubinstein L. Incarceration, drug use, and infectious diseases: a syndemic still not addressed. Lancet Infect Dis. 2018;18(12):1301\u20132. Available from: https:\/\/www.thelancet.com\/journals\/laninf\/article\/PIIS1473-3099(18)30538-3\/fulltext. Cited 2022 July 21.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"26437_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/2194-7899-1-3","volume":"1","author":"L Brinkley-Rubinstein","year":"2013","unstructured":"Brinkley-Rubinstein L. Incarceration as a catalyst for worsening health. Health Justice. 2013;1(1):3. https:\/\/doi.org\/10.1186\/2194-7899-1-3.","journal-title":"Health Justice"},{"issue":"S1","key":"26437_CR32","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2105\/AJPH.2019.305486","volume":"110","author":"L Brinkley-Rubinstein","year":"2020","unstructured":"Brinkley-Rubinstein L, Cloud DH. Mass incarceration as a social-structural driver of health inequities: a supplement to AJPH. Am J Public Health. 2020;110(S1):S14-5. Available from: https:\/\/ajph.aphapublications.org\/doi\/10.2105\/AJPH.2019.305486. Cited 2021 Aug 13.","journal-title":"Am J Public Health."},{"key":"26437_CR33","doi-asserted-by":"publisher","unstructured":"Howell BA, Earnshaw VA, Garcia M, Taylor A, Martin K, Fox AD. The Stigma of Criminal Legal Involvement and Health: a Conceptual Framework. J Urban Health. 2022; https:\/\/doi.org\/10.1007\/s11524-021-00599-y. Cited 2022 Jan 31.","DOI":"10.1007\/s11524-021-00599-y"},{"key":"26437_CR34","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev-soc-073014-112326","volume":"41","author":"M Massoglia","year":"2015","unstructured":"Massoglia M, Pridemore WA. Incarceration and health. Annu Rev Sociol. 2015;41:291\u2013310.","journal-title":"Annu Rev Sociol"},{"issue":"10077","key":"26437_CR35","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/S0140-6736(17)30259-3","volume":"389","author":"C Wildeman","year":"2017","unstructured":"Wildeman C, Wang EA. Mass incarceration, public health, and widening inequality in the USA. Lancet. 2017;389(10077):1464\u201374. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0140673617302593. Cited 2019 Sept 29.","journal-title":"The Lancet."},{"key":"26437_CR36","unstructured":"MacGowan RJ. HIV testing implementation guidance for correctional settings. Centers for Disease Control and Prevention, editor. 2009; Available from: https:\/\/stacks.cdc.gov\/view\/cdc\/5279."},{"issue":"8","key":"26437_CR37","doi-asserted-by":"publisher","first-page":"e0272374","DOI":"10.1371\/journal.pone.0272374","volume":"17","author":"M Maner","year":"2022","unstructured":"Maner M, Omori M, Brinkley-Rubinstein L, Beckwith CG, Nowotny K. Infectious disease surveillance in U.S. jails: findings from a national survey. PLOS ONE. 2022;17(8):e0272374. Available from: https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0272374. Cited 2022 Aug 28.","journal-title":"PLOS ONE."},{"key":"26437_CR38","unstructured":"Maruschak LM, Bronson J. HIV in Prisons, 2015 - Statistical Tables. Bureau of Justice Statistics; 2017 p. 18. (HIV in Prisons and Jails). Report No.: NCJ 250641. Available from: https:\/\/bjs.ojp.gov\/library\/publications\/hiv-prisons-2015-statistical-tables. Cited 2021 June 21."},{"issue":"3","key":"26437_CR39","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1377\/hlthaff.2013.1115","volume":"33","author":"L Solomon","year":"2014","unstructured":"Solomon L, Montague BT, Beckwith CG, Baillargeon J, Costa M, Dumont D, et al. Survey finds that many prisons and jails have room to improve HIV testing and coordination of postrelease treatment. Health Affairs. 2014;33(3):434\u201342. Available from: https:\/\/www.healthaffairs.org\/doi\/10.1377\/hlthaff.2013.1115. Cited 2021 Mar 30.","journal-title":"Health Affairs."},{"issue":"4","key":"26437_CR40","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1089\/jchc.20.04.0018","volume":"27","author":"AG Wurcel","year":"2021","unstructured":"Wurcel AG, Chen G, Zubiago JA, Reyes J, Nowotny KM. Heterogeneity in jail nursing medical intake forms: a content analysis. J Correct Health Care. 2021;27(4):265\u201371. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8875295\/. Cited 2022 July 21.","journal-title":"J Correct Health Care."},{"key":"26437_CR41","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181f9c0f7","author":"CG Beckwith","year":"2010","unstructured":"Beckwith CG, Zaller ND, Fu JJS, Montague BTD, Rich JDM. Opportunities to diagnose, treat, and prevent HIV in the criminal justice system. JAIDS J Acquir Immune Defic Syndr. 2010. https:\/\/doi.org\/10.1097\/QAI.0b013e3181f9c0f7.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"8","key":"26437_CR42","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1089\/apc.2012.0457","volume":"27","author":"L Brinkley-Rubinstein","year":"2013","unstructured":"Brinkley-Rubinstein L, Turner WL. Health impact of incarceration on HIV-positive African American males: a Qualitative Exploration. AIDS Patient Care and STDs. 2013;27(8):450\u20138. Available from: https:\/\/www.liebertpub.com\/doi\/10.1089\/apc.2012.0457. Cited 2022 May 23.","journal-title":"AIDS Patient Care and STDs."},{"issue":"7","key":"26437_CR43","doi-asserted-by":"publisher","first-page":"E5","DOI":"10.2105\/AJPH.2015.302635","volume":"105","author":"PA Iroh","year":"2015","unstructured":"Iroh PA, Mayo H, Nijhawan AE. The HIV care cascade before, during, and after incarceration: a systematic review and data synthesis. Am J Public Health. 2015;105(7):E5-16.","journal-title":"Am J Public Health"},{"issue":"4","key":"26437_CR44","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s11524-009-9348-5","volume":"86","author":"MR Khan","year":"2009","unstructured":"Khan MR, Doherty IA, Schoenbach VJ, Taylor EM, Epperson MW, Adimora AA. Incarceration and high-risk sex partnerships among men in the United States. J Urban Health. 2009;86(4):584\u2013601.","journal-title":"J Urban Health"},{"issue":"S1","key":"26437_CR45","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.2105\/AJPH.2019.305410","volume":"110","author":"AK Knittel","year":"2020","unstructured":"Knittel AK, Shook-Sa BE, Rudolph J, Edmonds A, Ramirez C, Cohen M, et al. Incarceration and Number of Sexual Partners After Incarceration Among Vulnerable US Women, 2007\u20132017. Am J Public Health. 2020;110(S1):S100\u20138.","journal-title":"Am J Public Health"},{"key":"26437_CR46","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jsat.2015.11.004","volume":"62","author":"JA Maradiaga","year":"2016","unstructured":"Maradiaga JA, Nahvi S, Cunningham CO, Sanchez J, Fox AD. \u201cI Kicked the Hard Way. I Got Incarcerated.\u201d withdrawal from methadone during incarceration and subsequent aversion to medication assisted treatments. J Substance Abuse Treat. 2016;62:49\u201354. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0740547215002871. Cited 2019 Nov 11.","journal-title":"J Substance Abuse Treat"},{"issue":"10049","key":"26437_CR47","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/S0140-6736(16)30379-8","volume":"388","author":"JD Rich","year":"2016","unstructured":"Rich JD, Beckwith CG, Macmadu A, Marshall BDL, Brinkley-Rubinstein L, Amon JJ, et al. Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis. Lancet. 2016;388(10049):1103\u201314. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0140673616303798. Cited 2022 May 25.","journal-title":"Lancet."},{"issue":"7","key":"26437_CR48","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1093\/cid\/cir491","volume":"53","author":"RP Westergaard","year":"2011","unstructured":"Westergaard RP, Kirk GD, Richesson DR, Galai N, Mehta SH. Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy. Clin Infect Dis. 2011;53(7):725\u201331. https:\/\/doi.org\/10.1093\/cid\/cir491.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"26437_CR49","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1177\/003335490512000208","volume":"120","author":"E Wood","year":"2005","unstructured":"Wood E, Li K, Small W, Montaner JS, Schechter MT, Kerr T. Recent incarceration independently associated with syringe sharing by injection drug users. Public Health Rep. 2005;120(2):150\u20136. https:\/\/doi.org\/10.1177\/003335490512000208. Cited 2021 June 25.","journal-title":"Public Health Rep"},{"issue":"12","key":"26437_CR50","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.2105\/AJPH.2018.304673","volume":"108","author":"JA Barocas","year":"2018","unstructured":"Barocas JA, White LF, Wang J, Walley AY, LaRochelle MR, Bernson D, et al. Estimated prevalence of opioid use disorder in Massachusetts, 2011\u20132015: a capture-recapture analysis. Am J Public Health. 2018;108(12):1675\u201381.","journal-title":"Am J Public Health"},{"key":"26437_CR51","unstructured":"Centers for Disease Control and Prevention. CDC National Center for Health Statistics website. 2022. Drug Overdose Mortality by State. Available from: https:\/\/www.cdc.gov\/nchs\/pressroom\/sosmap\/drug_poisoning_mortality\/drug_poisoning.htm. Cited 2022 July 19."},{"key":"26437_CR52","doi-asserted-by":"crossref","unstructured":"Gladden RM, Martinez P, Seth P. Fentanyl Law Enforcement Submissions and Increases in Synthetic Opioid\u2013Involved Overdose Deaths \u2014 27 States, 2013\u20132014. MMWR Morb Mortal Wkly Rep. 2016;65. Available from: https:\/\/www.cdc.gov\/mmwr\/volumes\/65\/wr\/mm6533a2.htm. Cited 2022 July 19.","DOI":"10.15585\/mmwr.mm6533a2"},{"key":"26437_CR53","doi-asserted-by":"crossref","unstructured":"O\u2019Donnell JK. Deaths Involving Fentanyl, Fentanyl Analogs, and U-47700 \u2014 10 States, July\u2013December 2016. MMWR Morb Mortal Wkly Rep. 2017;66. Available from: https:\/\/www.cdc.gov\/mmwr\/volumes\/66\/wr\/mm6643e1.htm. Cited 2022 July 19.","DOI":"10.15585\/mmwr.mm6643e1"},{"issue":"14","key":"26437_CR54","doi-asserted-by":"publisher","first-page":"382","DOI":"10.15585\/mmwr.mm6614a2","volume":"66","author":"NJ Somerville","year":"2017","unstructured":"Somerville NJ, O\u2019Donnell J, Gladden RM, Zibbell JE, Green TC, Younkin M, et al. Characteristics of fentanyl overdose \u2014 Massachusetts, 2014\u20132016. MMWR Morb Mortal Wkly Rep. 2017;66(14):382\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"26437_CR55","unstructured":"Cranston K. Notes from the Field: HIV Diagnoses Among Persons Who Inject Drugs \u2014 Northeastern Massachusetts, 2015\u20132018. MMWR Morb Mortal Wkly Rep. 2019;68. Available from: https:\/\/www.cdc.gov\/mmwr\/volumes\/68\/wr\/mm6810a6.htm. Cited 2021 May 7."},{"key":"26437_CR56","unstructured":"Madoff L, Brown CM, Lo J, S\u00e1nchez S. Joint MDPH and BHPC Clinical Advisory: Increase in newly diagnosed HIV infections among persons who inject drugs in Boston, March 15, 2021. Massachusetts Department of Public Health; 2021. Available from: https:\/\/www.mass.gov\/doc\/joint-mdph-and-bphc-clinical-advisory-hiv-transmission-through-injection-drug-use-in-boston-march-15-2021."},{"key":"26437_CR57","unstructured":"Massachusetts Department of Public Health. Massachusetts HIV\/AIDS Epidemiologic Profile, Detailed Data Tables \u2013 Data as of 1\/1\/2020. Massachusetts Department of Public Health, Bureau of Infectious Disease and Laboratory Sciences; 2020. Available from: https:\/\/www.mass.gov\/lists\/hivaids-epidemiologic-profiles. Cited 2021 May 7."},{"key":"26437_CR58","doi-asserted-by":"publisher","first-page":"108280","DOI":"10.1016\/j.jsat.2021.108280","volume":"124","author":"JL Taylor","year":"2021","unstructured":"Taylor JL, Ruiz-Mercado G, Sperring H, Bazzi AR. A collision of crises: addressing an HIV outbreak among people who inject drugs in the midst of COVID-19. J Subst Abuse Treat. 2021;124:108280. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8004551\/. Cited 2022 July 19.","journal-title":"J Subst Abuse Treat."},{"issue":"2","key":"26437_CR59","doi-asserted-by":"publisher","first-page":"174","DOI":"10.2307\/3096941","volume":"44","author":"DD Heckathorn","year":"1997","unstructured":"Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations studying hidden populations. Soc Probs. 1997;44(2):174\u201399. Available from: https:\/\/heinonline.org\/HOL\/P?h=hein.journals\/socprob44&i=184. Cited 2021 Nov 24.","journal-title":"Soc Probs."},{"issue":"Supplement 1","key":"26437_CR60","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/00333549071220S108","volume":"122","author":"A Lansky","year":"2007","unstructured":"Lansky A, Abdul-Quader AS, Cribbin M, Hall T, Finlayson TJ, Garfein RS, et al. Developing an HIV behavioral surveillance system for injecting drug users: the national HIV behavioral surveillance system. Public Health Rep. 2007;122(Supplement 1):48\u201355. https:\/\/doi.org\/10.1177\/00333549071220S108.","journal-title":"Public Health Rep"},{"key":"26437_CR61","doi-asserted-by":"crossref","unstructured":"Malekinejad M, Johnston LG, Kendall C, Kerr LR, Franco, Sansigolo, et al. Using Respondent-Driven Sampling Methodology for HIV Biological and Behavioral Surveillance in International Settings: a systematic review. AIDS and Behavior. 2008;12:105\u201330. Available from: https:\/\/www.proquest.com\/docview\/211220136\/abstract\/3EB7EB02D2F343E9PQ\/1. Cited 2022 July 22.","DOI":"10.1007\/s10461-008-9421-1"},{"key":"26437_CR62","unstructured":"Centers for Disease Control and Prevention. National HIV Behavioral Surveillance System Round 5: Model Surveillance Protocol. 2018. Available from: www.cdc.gov\/hiv\/statistics\/systems\/nhbs\/operations.html. Cited 2022 July 12."},{"key":"26437_CR63","unstructured":"Centers for Disease Control and Prevention. National HIV Behavioral Surveillance System Round 4: Model Surveillance Protocol. 2015. Available from: www.cdc.gov\/hiv\/statistics\/systems\/nhbs\/operations.html. Cited 2022 July 12."},{"issue":"7","key":"26437_CR64","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/aje\/kwh090","volume":"159","author":"G Zou","year":"2004","unstructured":"Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702\u20136. https:\/\/doi.org\/10.1093\/aje\/kwh090.","journal-title":"Am J Epidemiol"},{"issue":"6","key":"26437_CR65","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1177\/0962280211427759","volume":"22","author":"GY Zou","year":"2013","unstructured":"Zou GY, Donner A. Extension of the modified Poisson regression model to prospective studies with correlated binary data. Stat Methods Med Res. 2013;22(6):661\u201370. Available from: https:\/\/www.proquest.com\/docview\/1462848429\/abstract\/50CFC997CCB6409BPQ\/1. Cited 2022 July 25.","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"26437_CR66","doi-asserted-by":"publisher","first-page":"23","DOI":"10.15585\/mmwr.mm6701a5","volume":"67","author":"JC Burnett","year":"2018","unstructured":"Burnett JC, Broz D, Spiller MW, Wejnert C, Paz-Bailey G. HIV infection and HIV-associated behaviors among persons who inject drugs \u2014 20 Cities, United States, 2015. MMWR Morb Mortal Wkly Rep. 2018;67(1):23\u20138. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5769798\/. Cited 2021 June 16.","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"1","key":"26437_CR67","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13722-017-0078-9","volume":"12","author":"BH Lambdin","year":"2017","unstructured":"Lambdin BH, Kral AH, Comfort M, Lopez AM, Lorvick J. Associations of criminal justice and substance use treatment involvement with HIV\/HCV testing and the HIV treatment cascade among people who use drugs in Oakland, California. Addict Sci Clin Pract. 2017;12(1):13.","journal-title":"Addict Sci Clin Pract"},{"issue":"4","key":"26437_CR68","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s10461-018-02381-9","volume":"23","author":"CE Farel","year":"2019","unstructured":"Farel CE, Golin CE, Ochtera RD, Rosen DL, Margolis M, Powell W, et al. Underutilization of HIV testing among men with incarceration histories. AIDS Behav. 2019;23(4):883\u201392.","journal-title":"AIDS Behav"},{"key":"26437_CR69","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3389\/fpubh.2016.00076","volume":"4","author":"M Gwadz","year":"2016","unstructured":"Gwadz M, Cleland CM, Kutnick A, Leonard NR, Ritchie AS, Lynch L, et al. Factors associated with recent HIV testing among heterosexuals at high risk for HIV infection in New York City. Front Public Health. 2016;4:76. Available from: https:\/\/www.frontiersin.org\/article\/10.3389\/fpubh.2016.00076. Cited 2022 Jan 5.","journal-title":"Front Public Health."},{"issue":"1_suppl","key":"26437_CR70","doi-asserted-by":"publisher","first-page":"63S","DOI":"10.1177\/0033354919833435","volume":"134","author":"A Wise","year":"2019","unstructured":"Wise A, Finlayson T, Sionean C, Paz-Bailey G. Incarceration, HIV risk-related behaviors, and partner characteristics among heterosexual men at increased risk of HIV infection, 20 US cities. Public Health Rep. 2019;134(1_suppl):63S-70S. https:\/\/doi.org\/10.1177\/0033354919833435.","journal-title":"Public Health Rep"},{"issue":"Suppl 3","key":"26437_CR71","doi-asserted-by":"publisher","first-page":"S261","DOI":"10.1097\/QAI.0000000000001401","volume":"75","author":"A Wise","year":"2017","unstructured":"Wise A, Finlayson T, Nerlander L, Sionean C, Paz-Bailey G, NHBS Study Group. Incarceration, sexual risk-related behaviors, and HIV infection among women at increased risk of HIV infection, 20 United States Cities. J Acquir Immune Defic Syndr. 2017;75(Suppl 3):S261-7.","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"12","key":"26437_CR72","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/S1473-3099(18)30469-9","volume":"18","author":"J Stone","year":"2018","unstructured":"Stone J, Fraser H, Lim AG, Walker JG, Ward Z, MacGregor L, et al. Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Infect Dis. 2018;18(12):1397\u2013409. Available from: https:\/\/www.thelancet.com\/journals\/laninf\/article\/PIIS1473-3099(18)30469-9\/fulltext. Cited 2022 July 21.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"26437_CR73","doi-asserted-by":"publisher","first-page":"e0198258","DOI":"10.1371\/journal.pone.0198258","volume":"13","author":"BO Ojikutu","year":"2018","unstructured":"Ojikutu BO, Srinivasan S, Bogart LM, Subramanian SV, Mayer KH. Mass incarceration and the impact of prison release on HIV diagnoses in the US South. PLOS ONE. 2018;13(6):e0198258. Available from: https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0198258. Cited 2021 June 25.","journal-title":"PLOS ONE."},{"issue":"10072","key":"26437_CR74","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/S0140-6736(17)30003-X","volume":"389","author":"M Singer","year":"2017","unstructured":"Singer M, Bulled N, Ostrach B, Mendenhall E. Syndemics and the biosocial conception of health. Lancet. 2017;389(10072):941\u201350. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S014067361730003X. Cited 2022 July 21.","journal-title":"Lancet."},{"issue":"4","key":"26437_CR75","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/COH.0000000000000631","volume":"15","author":"DJ Bromberg","year":"2020","unstructured":"Bromberg DJ, Mayer KH, Altice FL. Identifying and managing infectious disease syndemics in patients with HIV. Curr Opin HIV AIDS. 2020;15(4):232\u201342. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7376494\/. Cited 2022 July 21.","journal-title":"Curr Opin HIV AIDS."},{"issue":"10279","key":"26437_CR76","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S0140-6736(21)00391-3","volume":"397","author":"SL Hodder","year":"2021","unstructured":"Hodder SL, Feinberg J, Strathdee SA, Shoptaw S, Altice FL, Ortenzio L, et al. The opioid crisis and HIV in the USA: deadly synergies. Lancet. 2021;397(10279):1139\u201350. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0140673621003913. Cited 2021 May 24.","journal-title":"Lancet."},{"key":"26437_CR77","unstructured":"Massachusetts General Laws, Part I, Title XVI, Chapter 111, Section 70F. Available from: https:\/\/malegislature.gov\/Laws\/GeneralLaws\/PartI\/TitleXVI\/Chapter111\/Section70F. Cited 2024 Feb 27."},{"key":"26437_CR78","unstructured":"Health Resources and Services Administration. Policy Clarification Notice #16\u201302 - Ryan White HIV\/AIDS Program Services: Eligible Individuals & Allowable Uses of Funds. Health Resources and Services Administration Ryan White HIV\/AIDS Program; 2018. Report No.: PCN #16\u201302. Available from: https:\/\/ryanwhite.hrsa.gov\/sites\/default\/files\/ryanwhite\/grants\/service-category-pcn-16-02-final.pdf. Cited 2024 Feb 8."},{"issue":"11","key":"26437_CR79","doi-asserted-by":"publisher","first-page":"e7648","DOI":"10.1371\/journal.pone.0007648","volume":"4","author":"R Kavasery","year":"2009","unstructured":"Kavasery R, Maru DSR, Cornman-Homonoff J, Sylla LN, Smith D, Altice FL. Routine opt-out HIV testing strategies in a female jail setting: a prospective controlled trial. PLoS ONE. 2009;4(11):e7648.","journal-title":"PLoS ONE"},{"issue":"6","key":"26437_CR80","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1177\/0033354917732755","volume":"132","author":"C de la Flor","year":"2017","unstructured":"de la Flor C, Porsa E, Nijhawan AE. Opt-out HIV and Hepatitis C testing at the Dallas County Jail: uptake, prevalence, and demographic characteristics of testers. Public Health Rep. 2017;132(6):617\u201321. https:\/\/doi.org\/10.1177\/0033354917732755.","journal-title":"Public Health Rep"},{"issue":"1","key":"26437_CR81","doi-asserted-by":"publisher","first-page":"e0262882","DOI":"10.1371\/journal.pone.0262882","volume":"17","author":"C Blue","year":"2022","unstructured":"Blue C, Buchbinder M, Brown ME, Bradley-Bull S, Rosen DL. Access to HIV care in jails: perspectives from people living with HIV in North Carolina. PLOS ONE. 2022;17(1):e0262882. Available from: https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0262882. Cited 2024 Feb 7.","journal-title":"PLOS ONE."},{"issue":"2","key":"26437_CR82","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/QAI.0000000000001664","volume":"78","author":"W Ly","year":"2018","unstructured":"Ly W, Cocohoba J, Chyorny A, Halpern J, Auerswald C, Myers J. Perspectives on integrated HIV and hepatitis C virus testing among persons entering a Northern California jail: a pilot study. J Acquir Immune Defic Syndr. 2018;78(2):214\u201320.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"26437_CR83","doi-asserted-by":"publisher","first-page":"e0286805","DOI":"10.1371\/journal.pone.0286805","volume":"18","author":"SR Levano","year":"2023","unstructured":"Levano SR, Epting ME, Pluznik JA, Philips V, Riback LR, Zhang C, et al. Hiv testing in jails: comparing strategies to maximize engagement in HIV treatment and prevention. PLoS ONE. 2023;18(6):e0286805.","journal-title":"PLoS ONE"},{"issue":"11","key":"26437_CR84","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1007\/s11606-022-07436-1","volume":"37","author":"J Alves","year":"2022","unstructured":"Alves J, Stewart J, Ruiz-Mercado G, Taylor JL. When perfect is the enemy of tested: a call to scale rapid HIV testing for people who inject drugs. J Gen Intern Med. 2022;37(11):2851\u20132.","journal-title":"J Gen Intern Med"},{"issue":"2","key":"26437_CR85","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1177\/1078345818762107","volume":"24","author":"AE Nijhawan","year":"2018","unstructured":"Nijhawan AE, Iroh PA, Porsa E. Acceptability of HIV testing among jail inmates when combined with a blood test for tuberculosis. J Correct Health Care. 2018;24(2):120\u20136. https:\/\/doi.org\/10.1177\/1078345818762107.","journal-title":"J Correct Health Care"},{"issue":"5","key":"26437_CR86","doi-asserted-by":"publisher","first-page":"e0251756","DOI":"10.1371\/journal.pone.0251756","volume":"16","author":"KA Faryar","year":"2021","unstructured":"Faryar KA, Ancona RM, Reau Z, Lyss SB, Braun RS, Rademaker T, et al. HIV detection by an emergency department HIV screening program during a regional outbreak among people who inject drugs. PLOS ONE. 2021;16(5):e0251756. Available from: https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0251756. Cited 2023 Dec 7.","journal-title":"PLOS ONE."},{"issue":"5","key":"26437_CR87","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.annemergmed.2014.05.021","volume":"64","author":"KI Geren","year":"2014","unstructured":"Geren KI, Lovecchio F, Knight J, Fromm R, Moore E, Tomlinson C, et al. Identification of acute HIV infection using fourth-generation testing in an opt-out emergency department screening program. Ann Emerg Med. 2014;64(5):537\u201346.","journal-title":"Ann Emerg Med"},{"issue":"6","key":"26437_CR88","doi-asserted-by":"publisher","first-page":"ofae189","DOI":"10.1093\/ofid\/ofae189","volume":"11","author":"SA Assoumou","year":"2024","unstructured":"Assoumou SA, Bonilla HV, Ruiz-Mercado G, Von Lossnitzer M, Baker R, Crawford ND, et al. Community-based HIV self-testing for persons who use drugs can contribute to reaching ending the HIV epidemic in the US (EHE) goals. Open Forum Infect Dis. 2024;11(6):ofae189. https:\/\/doi.org\/10.1093\/ofid\/ofae189.","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"26437_CR89","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/ADM.0000000000000801","volume":"15","author":"L Harvey","year":"2021","unstructured":"Harvey L, Taylor JL, Assoumou SA, Kehoe J, Schechter-Perkins EM, Bernstein E, et al. Sexually transmitted and blood-borne infections among patients presenting to a low-barrier substance use disorder medication clinic. J Addict Med. 2021;15(6):461\u20137.","journal-title":"J Addict Med"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-26437-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-26437-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-26437-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:24:01Z","timestamp":1781630641000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-26437-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["26437"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-26437-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5367945\/v1","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"31 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the Massachusetts Department of Public Health. The data analyzed in this study was collected by the Massachusetts Department of Public Health from community-dwelling participants as part of the National HIV Behavioral Surveillance (NHBS) program, supported by the US Centers for Disease Control and Prevention. Participation was anonymous and voluntary. Verbal informed consent was obtained from every participant before administration of the survey and performance of the HIV test. Financial incentives were offered for completion of the survey, HIV test, and recruitment of additional participants, respectively. After completion, participants were informed of their HIV test results and (if indicated) referred to treatment or other services while maintaining their anonymity with respect to NHBS participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"745"}}